UTZ: Utz Brands, Inc. Stock

SIC 209 – Miscellaneous Food Preparations And Kindred

Valuation
Market Cap ($M) 1,474.68
Enterprise Value ($M) 2,856.89
Book Value ($M) 1,390.09
Book Value / Share 17.06
Price / Book 1.06
NCAV ($M) -906.38
NCAV / Share -11.12
Price / NCAV -1.63

Profitability (mra)
Return on Invested Capital (ROIC) -0.01
Return on Assets (ROA) -0.01
Return on Equity (ROE) -0.01

Liquidity (mrq)
Quick Ratio 0.95
Current Ratio 1.40

Balance Sheet (mrq) ($M)
Current Assets 328.78
Assets 2,625.25
Liabilities 1,235.16
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,438.24
Operating Income 34.17
Net Income -24.94
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 76.64
Cash from Investing -48.49
Cash from Financing -49.05

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-01 13G Integrated Core Strategies (us) Llc 5.10
03-06 13D/A Series R of UM Partners, LLC 36.10 -0.88
02-14 13G T. Rowe Price Investment Management, Inc. 5.10 -26.51
02-13 13G/A Giordano Jason K 7.59 -18.68
02-13 13G/A Deromedi Roger K 8.36 -0.01
02-13 13G/A Champlain Investment Partners, LLC 6.94 3.85
02-13 13G/A Vanguard Group Inc 8.36 -0.87
02-12 13G Neuberger Berman Group LLC 5.81 30.43
01-26 13G/A BlackRock Inc. 6.90 32.08
01-25 13G/A Jpmorgan Chase & Co 6.20 0.67
01-09 13G/A Df Dent & Co Inc -11.82

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SE
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 1, 2023 OR ☐ TRANSITION REPORT PURSUANT
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 2, 2023 OR ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-16 87,237 562,286 15.51
2024-05-15 84,561 655,233 12.91
2024-05-14 60,361 611,998 9.86
2024-05-13 137,531 803,049 17.13

(click for more detail)

Similar Companies
MED – Medifast, Inc. MKC – McCormick & Company, Incorporated
MKC.V – McCormick & Company, Incorporated


Financial data and stock pages provided by
Fintel.io